agilon health (NYSE:AGL) Soars 236% on Q1 Beat, Raised Outlook; Outpatient Sector Rallies

agilon health (NYSE:AGL) shares surged 236% to $93.64 as of June 5, 2026, after the value-based care platform reported first-quarter revenue of $1.42 billion, beating analysts’ estimates by 3.2%, and raised its full-year EBITDA guidance well above expectations. Despite a 7.3% year-over-year revenue decline and a loss of 85,000 members, the raised outlook drove the stock’s rally. The outpatient and specialty care sector broadly outperformed, with a group of seven tracked companies posting a combined 1.9% revenue beat and an average 35% share price gain since their respective earnings reports. LifeStance Health (NASDAQ:LFST) saw revenue jump 21.2% to $403.5 million, the group’s fastest growth, while DaVita (NYSE:DVA) grew revenue 6% to $3.42 billion and lifted its full-year EPS guidance. The sector benefits from aging demographics and a shift toward cost-effective outpatient care, though reimbursement rate risks and labor shortages persist.